Central European Journal of Medicine

, Volume 3, Issue 3, pp 361–364 | Cite as

Treatment questions in POTS with hypertension and syncope

  • Malgorzata Lelonek
  • Jan Henryk Goch
Case Report


A 27-year old man experienced recurrent syncope with prodromal palpitations and resultant injury. The features of these episodes suggested a potentially neurally-mediated mechanism. Head-up tilt test revealed the postural orthostatic tachycardia syndrome (POTS). Within the first minutes of upright posture during the total head-up tilt testing, a heart rate increase of >30 beats/min and to a maximum of 150 beats/min was documented in the patient. At the end of passive tilting, the patient lost consciousness in the absence of hypotension while in sinus rhythm of 140 bpm. The 12-lead ECG and electrophysiological study showed no abnormalities. The patient received a beta-adrenergic blocker, a selective central imidazoline receptor agonist and psychiatric therapy, resulting in only a short-term improvement.

Key words

Syncope POTS Hypertension 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Grubb B.P., Kosinski D.J., Boehm K., Kip K., The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing, Pacing Clin. Electrophysiol., 1997, 20, 2205–2212PubMedCrossRefGoogle Scholar
  2. [2]
    Jauregui-Renaud K., Hermosillo J.A.G., Jardon J.L., Marquez M.F., Kostine A., Silva M.A., et al., Cerebral blood flow during supine rest and the first minute of head-up tilt in patients with orthostatic intolerance, Europace, 2005, 7, 460–464PubMedCrossRefGoogle Scholar
  3. [3]
    Goldstein D.S., Eldadah B., Holmes C., Pechnik S., Moak J., Sharabi Y., Neurocirculatory abnormalities in chronic orthostatic intolerance, Circulation, 2005, 111, 839–845PubMedCrossRefGoogle Scholar
  4. [4]
    Streeten D.H.P., Anderson G.H. Jr, Richardson R., Thomas F.D., Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: evidence for excessive venous pooling, J. Lab. Clin. Med., 1988, 111, 326–335PubMedGoogle Scholar
  5. [5]
    Jacob G., Shannon J., Costa F., Furlan R., Biaggioni I., Mosqueda-Garcia R., et al., Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance, Circulation, 1999, 98, 2154–2159Google Scholar
  6. [6]
    Shannon J.R., Flattem N.L., Jordan J., Jacob G., Black B.K., Biaggioniet I., al., Orthostatic intolerance and tachycardia associated with norepinephrine transporter deficiency, N. Engl. J. Med., 2000, 342, 541–549PubMedCrossRefGoogle Scholar
  7. [7]
    Goldstein D.S., Holmes C., Frank S.M., Dendi R., Cannon R.O. 3rd, Sharabi Y., et al., Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes, Circulation, 2002, 106, 2358–2365PubMedCrossRefGoogle Scholar
  8. [8]
    Grubb B.P., The postural tachycardia syndrome: etiology, diagnosis and treatment, In: Raviele A. (ed), Cardiac arrhythmias 2001, Springer Verlag, Milan Italia, 2002.Google Scholar
  9. [9]
    Shibao C., Arzubiaga C., Roberts L.J. 2nd, Raj S., Black B., Harris P., et al., Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders, Hypertension, 2005, 45, 385–390PubMedCrossRefGoogle Scholar
  10. [10]
    Ewan V., Norton M., Newton J.L., Symptom improvement in postural orthostatic tachycardia syndrome with the ninus node blocker ivabradine, Europace, 2007, 9, 1202PubMedCrossRefGoogle Scholar
  11. [11]
    Lelonek M., Goch J.H., The role of moxonidine in treatment of vasovagal patients with essential hypertension, Arterial Hypertension, 2005, 9, 4, 276–284, (in Polish)Google Scholar
  12. [12]
    Ernsberger P., Damon T.H., Graff L.M., Schafer S.G., Christen M.O., Moxonidine, a centrally acting antihypertensive agent, is a selective for I1-imidazoline sites, J. Pharmacol. Exp. Ther., 1993, 264, 172–182PubMedGoogle Scholar
  13. [13]
    Benrud-Larson L.M., Dewar M.S., Sandroni P., Rummans T.A., Haythornthwaite J.A., Low P.A., Quality of life in patients with postural tachycardia syndrome, Mayo Clin Proc, 2002, 77, 531–537PubMedCrossRefGoogle Scholar
  14. [14]
    Grubb B.P., Kanjwal M.Y., Kosinski D.J., The postural orthostatic tachycardia syndrome: current concepts in pathophysiology, diagnosis and management, J. Intervent. Cardiac Electrophysiol., 2001, 5, 9–16CrossRefGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  1. 1.Department of Cardiology, Chair of Cardiology and Cardiac SurgeryMedical University of LodzLodzPoland

Personalised recommendations